Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,152 INR | +1.81% | +7.02% | +6.25% |
Sales 2024 * | 287B 3.44B | Sales 2025 * | 314B 3.77B | Capitalization | 663B 7.95B |
---|---|---|---|---|---|
Net income 2024 * | 31.44B 377M | Net income 2025 * | 37.86B 454M | EV / Sales 2024 * | 2.25 x |
Net cash position 2024 * | 18.34B 220M | Net cash position 2025 * | 35.81B 429M | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
17.4
x | Employees | 23,451 |
Yield 2024 * |
0.36% | Yield 2025 * |
0.44% | Free-Float | 47.93% |
Latest transcript on Aurobindo Pharma
1 day | +1.81% | ||
1 week | +7.02% | ||
Current month | +5.79% | ||
1 month | +3.45% | ||
3 months | -0.78% | ||
6 months | +33.72% | ||
Current year | +6.25% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 26/86/26 | |
Director of Finance/CFO | - | 01/13/01 | |
B. Adi Reddy
CMP | Compliance Officer | - | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 26/86/26 | |
Founder | 66 | 26/86/26 | |
Director/Board Member | 64 | 27/03/27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 18 M€ | +4.62% | ||
0.12% | 11 M€ | +1.79% |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 1,152 | +1.81% | 2 471 250 |
26/24/26 | 1,131 | +2.53% | 1,511,617 |
25/24/25 | 1,103 | +1.78% | 1,642,872 |
24/24/24 | 1,084 | -0.84% | 923,839 |
23/24/23 | 1,093 | +1.58% | 1,150,312 |
Delayed Quote NSE India S.E., April 29, 2024 at 05:10 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.25% | 7.95B | |
+26.98% | 661B | |
+27.45% | 566B | |
-6.37% | 352B | |
+20.39% | 332B | |
+2.72% | 283B | |
+14.02% | 231B | |
+5.20% | 200B | |
-9.04% | 195B | |
-4.97% | 145B |
- Stock Market
- Equities
- AUROPHARMA Stock